Remove tag approval-processes
article thumbnail

STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease

STAT

SAN DIEGO — The sickle cell community has for the past few days been buzzing with news of the first-ever approved gene therapies for the devastating disease. These drugs have price tags of $2.2 million and $3.1 million, respectively.

article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

Her videos cover a host of topics from the science behind the immune system, side effects caused by the shots and vaccine hesitancy and the clinical and regulatory path to approval. Additionally, we will soon introduce a new vaccine tag to detect and tag all videos with words and hashtags related to the COVID-19 vaccine,” says Morgan. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar

pharmaphorum

Lucentis (ranibizumab) was first FDA approved in 2006 for wet age-related macular degeneration (wet AMD) and has picked up approvals in related eye conditions ever since, although its patent expired in June.

FDA 62
article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Build on the rapid responses to COVID-19. The mindset that accomplished this needs to be retained,” Jeremy says.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. . The Scottish Medicines Consortium is expected to publish its final advice on the drug later this year.

Hospitals 109
article thumbnail

Pear claims breakthrough tag for alcohol use disorder DTx

pharmaphorum

It was approved by the FDA in 2018 as an add-on to pharmacological treatment with buprenorphine to help opioid users stick with their recovery programme, for example by helping them identify triggers that cause them to relapse. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on.

FDA 57